Pacira Biosciences Inc(PCRX) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.

Current Price

$63.21

RSI

30.354

Beta:

1.146718

March 01, 2021
100M
462.7M
-6.9M

5.002 %
-1.001 %
458.458 %
277.810 %

$420,830,000
$421,026,000
$337,277,000
$286,630,000
$276,371,000
$248,997,000
-0.047 %
24.831 %
17.670 %
3.712 %
10.994 %

$20,089,000
$-10,748,000
$-425,000
$-42,471,000
$-37,844,000
$2,120,000
153.502 %
-96.046 %
9893.176 %
-10.894 %
-105.602 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.